WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 2'4601 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 4'6691 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 3'487  3'514  3'543  3'573  3'604  4'107  4'364  4'010 
Births 42  43  44  44  45  48  81  85 
Surviving infants 42  42  43  44  44  47  78  81 
Pop. less than 5 years 215  222  223  215  210  255  427  378 
Pop. less than 15 years 577  583  589  596  609  974  1'218  1'072 
Female 15-49 years 911  928  945  962  978  1'096  1'101  1'074 

Number of reported case

(Click for retrospective incidence data for Republic of Moldova (the))
Diphtheria 10 
Japanese encephalitis
Measles 27  11  687  3'242 
Mumps 60  131  143  144  292  1'942 
Pertussis 115  92  102  31  47  169  266 
Polio*
Rubella 2'803 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Republic of Moldova (the))
Vaccine year result method % card seen                                                
BCG 2004  100  DHS   90  96  99  98  98  99  99 
DTP1 2004  98  DHS   90  86  91  96  93  95  94 
DTP3 2004  94  DHS   90  90  92  93  90  94  95 
HepB_BD          95  99  99  99  99  93 
HepB3 2004  95  DHS   90  91  94  96  98  95  92 
Hib3          89  90  78  63  94 
JapEnc         
MCV 2004  91  DHS   90  91  91  91  97  91  89 
MCV2          94  95  97  98  98 
PCV1          17 
PCV3         
Pol3 2004  95  DHS   90  92  92  96  97  95  97 
Rota1          72  94 
Rota_last          65  93 
Rubella1          91  91  91  97  91 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Republic of Moldova (the))
BCG 96  99  98  98  96  99 
DTP1 96  97  96  93  88  98 
DTP3 90  92  93  90  85  95 
HepB3 91  94  96  98  89  92 
HepB_BD 95  99  99  98  98  93 
Hib3 89  90  78  63  47 
MCV 91  91  91  97  90  89 
MCV2 94  95  96  98  98 
PnC3
Pol3 92  92  96  97  87  97 
Rota_last 65  21 

Number of districts in the country 44  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 84
From 80 to 89% 9
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 days; 7 years; Yes
DT 7 years; Yes
DTwP 22 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes and adults in risk groups
Influenza Yes risk groups
MMR 12 months; 7, 15 years; Yes
OPV 2, 4, 6, 22 months; 7, 15 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 15, 20, 25, 30, 35, 40, 50, 60 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 44  44  44  44  44  44  44 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

System performance

Total Nº districts in country number 44  44  44  44  44  43  44 
Nº districts with DTP3 coverage >=80% number 41  42  42  40  38  41 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  95  95  91  86  95  18 
Nº districts with measles (MCV1) coverage >=95% number 18  22  30  37  25  32   
% of districts with MCV1 coverage >=95% From 0 to 100% 41  50  68  84  57  74   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 62  535    58  54  56  94 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.